Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.500
+0.170 (3.93%)
Jul 13, 2026, 4:00 PM EDT - Market closed
Camp4 Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| William Blair | William Blair | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 25, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Upgrades $9 | Buy | Upgrades | $9 | +100.00% | Jun 23, 2026 |
| Chardan Capital | Chardan Capital | Buy Initiates $6.5 | Buy | Initiates | $6.5 | +44.44% | Jun 10, 2026 |
| Piper Sandler | Piper Sandler | Buy Reiterates $12 | Buy | Reiterates | $12 | +166.67% | May 15, 2026 |
| Wedbush | Wedbush | Buy Maintains $8 | Buy | Maintains | $8 | +77.78% | May 8, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $7 | Buy | Maintains | $7 | +55.56% | May 8, 2026 |
| Rodman & Renshaw | Rodman & Renshaw | Buy Initiates $7 | Buy | Initiates | $7 | +55.56% | Apr 14, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $8 → $9 | Buy | Maintains | $8 → $9 | +100.00% | Apr 2, 2026 |